In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.

On October 6, 2015, the European Court of Justice (“ECJ”) ruled the US-EU Safe Harbor agreement invalid. The international agreement permitted companies to transfer digital information across the Atlantic, originating in the European Union (“E.U.”) and traveling to the United States (“U.S.”).